HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simon P Robinson Selected Research

Lactic Acid (Lactate)

1/2014Reduced Warburg effect in cancer cells undergoing autophagy: steady- state 1H-MRS and real-time hyperpolarized 13C-MRS studies.
10/2013¹H NMR and hyperpolarized ¹³C NMR assays of pyruvate-lactate: a comparative study.
7/2006The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy.
5/2005Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simon P Robinson Research Topics

Disease

73Neoplasms (Cancer)
01/2022 - 01/2002
18Hypoxia (Hypoxemia)
01/2021 - 02/2002
16Neuroblastoma
11/2020 - 07/2011
10Necrosis
04/2018 - 03/2006
10Prolactinoma (Prolactinomas)
09/2013 - 11/2002
8Glioma (Gliomas)
11/2018 - 08/2003
6Breast Neoplasms (Breast Cancer)
11/2020 - 06/2002
5Carcinoma (Carcinomatosis)
10/2018 - 05/2005
4Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 12/2008
4Neoplasm Metastasis (Metastasis)
12/2015 - 12/2008
3Rupture
01/2019 - 07/2014
3Inflammation (Inflammations)
01/2019 - 01/2015
3Atherosclerosis
01/2019 - 03/2011
3Prostatic Neoplasms (Prostate Cancer)
10/2018 - 04/2014
3Fibrosis (Cirrhosis)
04/2018 - 01/2010
3Squamous Cell Carcinoma of Head and Neck
01/2018 - 01/2016
3Colonic Neoplasms (Colon Cancer)
01/2016 - 03/2006
3Fibrosarcoma
07/2006 - 04/2003
2Atherosclerotic Plaque (Atheroma)
01/2019 - 03/2011
2Renal Cell Carcinoma (Grawitz Tumor)
01/2018 - 01/2017
2Aneurysm (Aneurysms)
01/2015 - 07/2014
2Vascular Remodeling
05/2014 - 10/2012
1Diffuse Intrinsic Pontine Glioma
01/2022

Drug/Important Bio-Agent (IBA)

34Biomarkers (Surrogate Marker)IBA
01/2021 - 05/2005
13Pharmaceutical PreparationsIBA
01/2018 - 01/2005
12ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
01/2017 - 04/2003
11carbogenIBA
03/2019 - 11/2002
11bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
01/2018 - 08/2003
10pimonidazoleIBA
04/2018 - 07/2004
10Contrast MediaIBA
01/2018 - 04/2003
9Oxygen (Dioxygen)IBA
01/2021 - 07/2004
8N-acetylcochinol-O-phosphateIBA
09/2015 - 03/2004
7ElastinIBA
01/2021 - 03/2011
5Choline (Choline Chloride)IBA
10/2018 - 02/2002
5deoxyhemoglobinIBA
08/2017 - 08/2003
4cediranib (AZD2171)IBA
01/2019 - 10/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2017 - 10/2012
4Lactic Acid (Lactate)FDA LinkGeneric
01/2014 - 05/2005
4Eosine Yellowish-(YS) (Eosin)IBA
03/2012 - 03/2006
3Phosphotransferases (Kinase)IBA
01/2020 - 11/2011
3CollagenIBA
11/2019 - 04/2015
3Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2018 - 08/2003
3Gadolinium DTPA (Magnevist)FDA Link
01/2018 - 03/2014
3CrizotinibIBA
01/2017 - 07/2012
3Hydralazine (Apresoline)FDA LinkGeneric
02/2016 - 11/2004
3EnzymesIBA
10/2013 - 02/2002
3dimethylargininaseIBA
11/2011 - 08/2003
3Hematoxylin (Haematoxylon)IBA
01/2010 - 03/2006
3vadimezanIBA
11/2007 - 05/2005
2Transcription Factors (Transcription Factor)IBA
11/2020 - 02/2002
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2019 - 01/2013
2Proteins (Proteins, Gene)FDA Link
10/2019 - 01/2016
2Indicators and Reagents (Reagents)IBA
03/2019 - 04/2004
2GadoliniumIBA
01/2019 - 03/2014
2Molecular Probes (Molecular Probe)IBA
01/2019 - 01/2019
2Doxycycline (Periostat)FDA LinkGeneric
11/2018 - 06/2016
2Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
04/2018 - 01/2010
2Antineoplastic Agents (Antineoplastics)IBA
01/2018 - 08/2008
2Anaplastic Lymphoma KinaseIBA
09/2017 - 01/2017
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2016 - 03/2006
2N-Myc Proto-Oncogene ProteinIBA
01/2016 - 11/2011
2TamoxifenFDA LinkGeneric
01/2016 - 06/2002
2Matrix Metalloproteinases (MMPs)IBA
06/2015 - 01/2015
2SolutionsIBA
04/2014 - 03/2004
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2014 - 10/2013
2Pyruvic Acid (Pyruvate)IBA
01/2014 - 10/2013
2azomycinIBA
09/2013 - 07/2004
2Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
12/2012 - 07/2011
2Adenosine Triphosphate (ATP)IBA
07/2012 - 02/2002
2AcidsIBA
05/2011 - 03/2006
2Phosphorylcholine (Phosphocholine)IBA
07/2006 - 02/2002
2Phosphates (Orthophosphate)IBA
05/2005 - 03/2004
2NucleosidesIBA
05/2005 - 02/2002
2triphosphoric acid (triphosphate)IBA
05/2005 - 02/2002
2Glucose (Dextrose)FDA LinkGeneric
07/2004 - 02/2002
1dipinacoline glutamateIBA
01/2022
1Interleukin-4 (Interleukin 4)IBA
11/2020
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
11/2020
1Temozolomide (Temodar)FDA LinkGeneric
11/2020
1CYC065IBA
11/2020
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2020
1veliparibIBA
06/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2020
1talazoparibIBA
06/2020
1niraparibIBA
06/2020
1olaparibIBA
06/2020
1vistusertibIBA
01/2020
1Aurora Kinase AIBA
01/2020
1MLN 8237IBA
01/2020
1Collagenases (Collagenase)FDA Link
11/2019
1RNA (Ribonucleic Acid)IBA
10/2019
1CyclinsIBA
10/2019
1Thymidine KinaseIBA
10/2019

Therapy/Procedure

31Therapeutics
01/2022 - 01/2002
9Radiotherapy
01/2021 - 01/2003
8Aftercare (After-Treatment)
01/2016 - 05/2005
4Drug Therapy (Chemotherapy)
01/2021 - 06/2004
2Precision Medicine
01/2020 - 01/2019
2Intravenous Administration
10/2016 - 07/2011
1Radiofrequency Ablation
01/2021